VivoSim Labs (VIVS) EBITDA Margin Growth (5y) (2016 - 2024)
VivoSim Labs (VIVS) EBITDA Margin Growth (5y) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.27 Mn |
| Sep 30, 2024 | -813,829.00 |
| Jun 30, 2024 | -770,585.00 |
| Mar 31, 2024 | -962,263.00 |
| Dec 31, 2023 | -7.28 Mn |
| Jun 30, 2023 | -449,362.00 |
| Mar 31, 2023 | -411,561.00 |
| Dec 31, 2022 | -187,817.00 |
| Sep 30, 2022 | -364,891.00 |
| Mar 31, 2022 | 118,872.00 |
| Dec 31, 2019 | 273,459.00 |
| Sep 30, 2019 | 347,919.00 |
| Jun 30, 2019 | 549,855.00 |
| Sep 30, 2018 | 4.00 Mn |
| Jun 30, 2018 | 242,293.00 |
| Dec 31, 2017 | 160,345.00 |
| Sep 30, 2017 | 462,780.00 |
| Jun 30, 2017 | -47,054.00 |
| Dec 31, 2016 | 4.19 Mn |
| Sep 30, 2016 | -42,056.00 |